Literature DB >> 26417876

Risk Factors for Chronic Renal Insufficiency Following Cardiac Transplantation.

Kim Lachance1, Michel White2, Simon de Denus1.   

Abstract

Although previous publications have discussed kidney disease in nonrenal solid-organ transplantation, none has reviewed thoroughly the potential predictors of long-term renal impairment in cardiac recipients. Thus, the purpose of this review article is to summarize the current state of knowledge on risk factors of chronic renal insufficiency in heart transplant patients. An English language Medline literature search (1946-April 2014) was conducted using the search terms renal insufficiency, kidney failure, kidney diseases, nephrotoxi$ ($ for truncation), creatinine, glomerular filtration rate, heart transplantation and organ transplantation. Additional references were identified from a review of literature citations. A total of 74 articles discussing key risk factors were included in the manuscript.         The existing literature reveals that several recipient characteristics (age, female sex, pretransplant/early post-transplant kidney impairment, diabetes, and hypertension) increase the risk of renal insufficiency after transplantation. Current data also indicate that, while cyclosporine and tacrolimus are most likely major determinants of post-transplant kidney failure, the effects of calcineurin inhibitor doses and concentrations remain unclear. A small number of studies suggest that tacrolimus could possibly induce less nephrotoxicity than cyclosporine, but meta-analyses of randomized controlled trials show the opposite with comparable incidences of dialysis after cardiac transplantation. Finally, the role of genetic variations has only been explored to a limited extent in heart transplant patients. This growing body of evidence should ultimately lead to a better risk prediction regarding chronic renal insufficiency following cardiac transplantation and a more personalized tailoring of immunosuppressive regimens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26417876     DOI: 10.12659/AOT.893788

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  7 in total

1.  Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation.

Authors:  Rasmus Rivinius; Carolin Gralla; Matthias Helmschrott; Fabrice F Darche; Philipp Ehlermann; Tom Bruckner; Wiebke Sommer; Gregor Warnecke; Stefan Kopf; Julia Szendroedi; Norbert Frey; Lars P Kihm
Journal:  Front Cardiovasc Med       Date:  2022-06-09

Review 2.  Outcomes With Left Ventricular Assist Device in End-Stage Renal Disease: A Systematic Review.

Authors:  Sofia Lakhdar; Mahmoud Nassar; Chandan Buttar; Laura M Guzman Perez; Shahzad Akbar; Anoosh Zafar; Most Munira
Journal:  Cureus       Date:  2022-04-18

3.  Longitudinal changes in kidney function following heart transplantation: Stanford experience.

Authors:  Adetokunbo A Taiwo; Kiran K Khush; Margaret R Stedman; Yuanchao Zheng; Jane C Tan
Journal:  Clin Transplant       Date:  2018-10-25       Impact factor: 2.863

4.  Temporal Changes on the Risks and Complications of Posttransplantion Diabetes Mellitus Following Cardiac Transplantation.

Authors:  Nadia Iannino; Amine Nasri; Agnès Räkel; Anique Ducharme; Kim Lachance; Normand Racine; Simon de Denus; Maxime Tremblay-Gravel; Annik Fortier; Michel White
Journal:  J Transplant       Date:  2018-11-08

5.  Heart and kidney transplant: should they be combined or subsequent?

Authors:  Inga Melvinsdottir; David P Foley; Timothy Hess; Sverrir I Gunnarsson; Takushi Kohmoto; Joshua Hermsen; Maryl R Johnson; David Murray; Ravi Dhingra
Journal:  ESC Heart Fail       Date:  2020-06-30

Review 6.  Post-cardiac transplant recipient: Implications for anaesthesia.

Authors:  Minati Choudhury
Journal:  Indian J Anaesth       Date:  2017-09

Review 7.  Cardiac Transplantation: Update on a Road Less Traveled.

Authors:  Tripti Gupta; Selim R Krim
Journal:  Ochsner J       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.